Table 1 Serum p53 antibodies in patients with epithelial ovarian cancer.
From: Immunologic aspect of ovarian cancer and p53 as tumor antigen
Reference | Total no of patients | No of patients with p53 serum antibodies (%) | Correlation with overall survival | ||
|---|---|---|---|---|---|
| Â | Â | In all patients | In patients with stage I/II disease | In patients with stage III/IV disease | Â |
[146] | 86 | 18 (21) | 3 (10) | 15 (27) | no1 |
[131] | 113 | 21 (19) | 3 (8) | 18 (23) | yes1,2 |
[147] | 83 | 38 (46) | 5 (26) | 33 (52) | no2 |
[148] | 193 | 24 (12) | 4 (6) | 20 (15) | no1,2 |
[149] | 33 | 12 (36) | 3 (21) | 9 (47) | yes1 |
[150] | 30 | 10 (33) | 2 (22) | 8 (38) | - |
[151] | 174 | 41 (24) | 8 (21) | 29 (28) | no1,2 |
[133] | 113 | 28 (25) | - | - | no1 |
[152] | 99 | 25 (25) | - | - | - |
[127] | 46 | 4 (9) | - | - | - |
[130] | 30 | 8 (27) | - | - | yes1 |
[153] | 30 | 8 (27) | - | - | - |
[129] | 40 | 15 (38) | - | - | - |
[126] | 46 | 4 (9) | - | - | - |
[154] | 38 | 11(29) | - | - | - |
| Â | 1154 | 267 (23) | 28 (13) | 132 (28) | Â |